arci.org 的前十大競爭對手

amyloidosis.org

JAMA Cardiol Published Online: November 8, 2025 Today at the AHA congress in New Orleans, BridgeBio presented data showing that acoramidis significantly reduces all-cause mortality (through month 42) in people living with hereditary ATTR-CM population, with specific benefit noted in those living with the V122i variant. These data have also been published today in JAMA Cardiology. You can read […]

myamyloidosisteam.com

MyAmyloidosisTeam | The social network and support group for those living with amyloidosis.

vyndamax.com

vyndamax® is an rx option used to treat both the wild-type & hereditary forms of transthyretin amyloid cardiomyopathy (attr-cm) in adults.

attr-amyloidosis.com

Stay up to date on the latest news about transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM) by signing up to receive informational emails.

wainua.com

Sign up with WAINUA Way support program to receive information about WAINUA and services related to your condition and treatment.

attrubyhcp.com

Explore up-to-date information about the Attruby® (acoramidis) clinical study primary endpoint, including ACM and CVH measures over 30 months

intelliatx.com

Learn more about life at Intellia, our culture, benefits and career opportunities.

lifescienceleader.com

Past Issues Of Life Science Leader

rettsyndrome.org

New research is breaking down outdated assumptions and bringing male experiences into full view.

atcp.org

The A-T Children’s Project partners with academic and industry investigators to optimize disease management strategies, develop new treatments and find a cure for A-T.